BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23536336)

  • 1. [Application and value of mutation detection in diagnosis and treatment of gastrointestinal stromal tumor].
    Cao H; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):208-11. PubMed ID: 23536336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular and genetic features of gastrointestinal stromal tumors (GIST)].
    Buleje S J; Yábar B A; Guevara-Fujita M; Fujita R
    Rev Gastroenterol Peru; 2012; 32(4):394-9. PubMed ID: 23307090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathology and molecular diagnostics of gastrointestinal stromal tumors.
    Lucas DR
    Curr Probl Cancer; 2011; 35(5):233-44. PubMed ID: 22118563
    [No Abstract]   [Full Text] [Related]  

  • 4. [Gastrointestinal stromal tumor molecular diagnostics in relation to the prediction of a therapeutic response to targeted biological therapy].
    Augustináková A; Kodet R
    Cesk Patol; 2011 Oct; 47(4):148-52. PubMed ID: 22145212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of oncogenic KIT and PDGFRA mutations in gastrointestinal stromal tumours.
    Lasota J; Miettinen M
    Histopathology; 2008 Sep; 53(3):245-66. PubMed ID: 18312355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors.
    Daum O; Grossmann P; Vanecek T; Sima R; Mukensnabl P; Michal M
    Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastrointestinal stromal tumors (GIST): at the forefront of targeted therapies].
    Emile JF
    Med Sci (Paris); 2013; 29(6-7):630-6. PubMed ID: 23859518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of gastrointestinal stromal tumors and implications for treatment and prognosis.
    Parkin B; Chugh R
    Curr Probl Cancer; 2011; 35(5):245-54. PubMed ID: 22118564
    [No Abstract]   [Full Text] [Related]  

  • 10. An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST).
    Nannini M; Biasco G; Astolfi A; Pantaleo MA
    J Med Genet; 2013 Oct; 50(10):653-61. PubMed ID: 23833252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O; Gouveia A; Viana-Pereira M; Silva P; Pimenta A; Reis RM; Lopes JM
    Histopathology; 2009 Jul; 55(1):53-62. PubMed ID: 19614767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
    Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN
    Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational profile of KIT and PDGFRA genes in gastrointestinal stromal tumors in Peruvian samples.
    Buleje J; Acosta Ó; Guevara-Fujita M; Enriquez Y; Taxa L; Machicado E; Lizaraso-Caparó F; Fujita R
    Rev Esp Enferm Dig; 2015 Feb; 107(2):72-8. PubMed ID: 25659388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gastrointestinal stromal tumors (GIST)].
    Jaros D; Bozic B; Sebesta C
    Wien Med Wochenschr; 2023 Jun; 173(9-10):201-205. PubMed ID: 36155864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal stromal tumors: a rare nosological entity and a model example for the use of personalized therapy with a molecular basis].
    Bettegazzi C; Erra S
    Recenti Prog Med; 2015 Jan; 106(1):52-7. PubMed ID: 25621782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of KIT and PDGFRA mutations in the plasma of patients with gastrointestinal stromal tumor.
    Kang G; Bae BN; Sohn BS; Pyo JS; Kang GH; Kim KM
    Target Oncol; 2015 Dec; 10(4):597-601. PubMed ID: 25735500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of signaling molecules in the prediction of response to imatinib treatment in metastatic GIST patients.
    Valadão M; Braggio D; Santos AF; Pimenta-Inada HK; Linhares E; Gonçalves R; Romano S; Vilhena B; Small I; Cubero D; Cruz F; Oliveira AT; Martinho O; Reis RM; Guimarães DP; Ferreira CG
    J Surg Res; 2012 Nov; 178(1):288-93. PubMed ID: 22516345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
    Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
    Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
    Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
    Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation status of known methylation-sensitive CpG islands in gastrointestinal stromal tumors without any correlation to the state of c-kit and PDGFRA gene mutations and their malignancy.
    Saito K; Sakurai S; Sano T; Sakamoto K; Asao T; Hosoya Y; Nakajima T; Kuwano H
    Cancer Sci; 2008 Feb; 99(2):253-9. PubMed ID: 18271923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.